In Brief
Thomas et al. now find that Cyclin B/Cdk1 phosphorylates SPAT-1/Bora to promote Plk1 activation in C. elegans and in human cells. They identify three conserved phosphorylation sites in SPAT-1 and Bora that promote timely mitotic entry in the embryo and G2-checkpoint recovery from DNA damage in human cells.
INTRODUCTION
Polo-like kinase 1 (Plk1) plays a pivotal role in cell division by controlling multiple processes including centrosome maturation, spindle assembly, chromosome segregation, and cytokinesis (Archambault and Glover, 2009 ). Plk1 is also essential for the development of multicellular organisms; for instance, it regulates polarity in sensory organ precursors (SOPs) and epithelial cells in flies (Shrestha et al., 2015; Wang et al., 2007) and coordinates polarity, cell fate, and the asynchrony of cell division in the early C. elegans embryo (Nishi et al., 2008; Budirahardja and Gö nczy, 2008; Rivers et al., 2008; Noatynska et al., 2013) .
After DNA damage, Plk1 is essential for G2-checkpoint recovery (van Vugt et al., 2004) . The kinases ATM (ataxia telengectasia mutated) and ATR (ataxia telengectasia mutated and Rad3-related) sense DNA damage and phosphorylate several substrates to promote checkpoint activation and DNA repair. Upon completion of DNA repair, the cell inactivates the checkpoint and resumes cell-cycle progression in a process termed ''G2-checkpoint recovery'' in which Plk1 plays a dual role: it inhibits checkpoint components and promotes progression through mitosis (Mailand et al., 2006; Mamely et al., 2006; van Vugt and Yaffe, 2010) .
Plk1 is characterized by an N-terminal kinase domain and a C-terminal non-catalytic region containing two tandem Polo boxes (Polo box domain [PBD] ; Cheng et al., 2003) . Spatial control of Plk1 function is mediated by the conserved PBD (Lee et al., 1998) , which recognizes peptides previously phosphorylated by other kinases (Elia et al., 2003) .
Plk1 kinase activity depends on its phosphorylation on a conserved threonine (Thr) residue (T210) located in the T-loop of the kinase domain (Jang et al., 2002) . This phosphorylation is mediated by the Aurora A kinase during both a normal mitosis (Seki et al., 2008b) and checkpoint recovery from DNA damage (Mac urek et al., 2008) . The efficiency of this phosphorylation requires Bora, originally identified in Drosophila melanogaster (Hutterer et al., 2006) . In human cells, Bora binds Plk1 and enhances Aurora A mediated T-loop phosphorylation of Plk1 (Seki et al., 2008b; Mac urek et al., 2008) .
Bora is phosphorylated by several kinases. Upon DNA damage, ATR phosphorylates Bora to target it for degradation, contributing to Plk1 inactivation and cell-cycle arrest (Qin et al., 2013) . Bora is also phosphorylated by other kinases including Cdk1 (Hutterer et al., 2006; Chan et al., 2008; Feine et al., 2014) , Gsk3 (Lee et al., 2013) , and Plk1 itself (Chan et al., 2008; Seki et al., 2008a) . Once mitosis starts, both Cdk1 and Plk1 target Bora to proteolysis (Seki et al., 2008a; Chan et al., 2008) . However, a fraction of Bora escapes degradation and is required to sustain Plk1 activity during mitosis . Hyperphosphorylated Bora accumulates at the G2-M transition and co-precipitates with Plk1 (Seki et al., 2008b; Chan et al., 2008) .
The C. elegans ortholog of Bora, SPAT-1 (suppressor of Partwo 1) (Labbé et al., 2006) , also functions as a PLK-1 activator (Noatynska et al., 2010) . Loss of spat-1 or plk-1 delays mitotic entry in early embryos. SPAT-1 is phosphorylated at multiple sites by Cdk1, and phosphorylation is essential for its function, although the exact sites crucial for the regulation of cell division timing have not been identified yet (Tavernier et al., 2015) .
Here, we show that Cdk1 phosphorylates Bora on multiple serine (Ser) and Thr residues but that phosphorylation of three conserved residues located in the N-terminal part of the protein promotes activation of Plk1 in vitro and is essential for mitotic entry after DNA damage in vivo. Moreover, we demonstrate that this pathway is conserved between worms and humans.
RESULTS
Cyclin B/Cdk1 Phosphorylates Bora at Multiple SP/TP Sites In Vitro and In Vivo Pre-phosphorylating Bora with Cyclin B/Cdk1 stimulates phosphorylation of Plk1 by Aurora A on its T-loop in vitro (Tavernier et al., 2015) . To further investigate the role of Cdk1-dependent Bora phosphorylation for Plk1 activation, we used liquid chromatography-tandem mass spectrometry (LC-MS/MS) to map Cdk1-dependent Bora phosphorylation sites in vitro (as described in Figures 1A and 1B) . Fourteen SP/TP sites were identified, distributed along the entire protein ( Figures 1F and S1B) .
We then investigated whether these sites were also phosphorylated in vivo. Indeed, it has been shown that Bora is maximally phosphorylated in G2 in HeLa cells (Seki et al., 2008b; Chan et al., 2008) when Plk1 and Cdk1 become activated. We generated a stable HEK293 cell line expressing Bora tagged with the FLAG epitope ( Figure S1A ). We synchronized cells using a double thymidine block and release protocol and found that Bora phosphorylation is maximum 4 hr after release from the thymidine block ( Figure 1C ). LC-MS/MS analysis of FLAG-Bora immunoprecipitates at this time point ( Figure 1D ) led to the identification of 12 phosphorylated Ser and Thr followed by proline on Bora, 10 of which were also identified in vitro (Figures 1F, S1B, and S1E; Table S1 ).
Analysis of Bora interaction partners confirmed the presence of not only Plk1 (Mac urek et al., 2008; Seki et al., 2008b; Chan et al., 2008) but also Cyclin B1 ( Figures 1E and S1D ). Both Cyclin B/Cdk1 and Cyclin A/Cdk1 are active at 4 hr ( Figure S1C ), but Cyclin A was not recovered in FLAG-Bora immunoprecipitates. Although we cannot exclude a contribution of Cyclin A/Cdk1 in these cells or in somatic cells, our data suggest that Cyclin B/Cdk1 is the major kinase phosphorylating Bora. In conclusion, Bora is phosphorylated at multiple SP/TP Cdk1 consensus sites.
An N-Terminal Fragment of Bora Containing the First 225 Amino Acids Supports Cdk1-Dependent Plk1 Activation In Vitro To find which sites are critical for Plk1 activation, we set to identify the minimal fragment of Bora supporting Cdk1-dependent Plk1 activation in vitro. We used a previously described assay that monitors the activity of Aurora A toward Plk1 in the presence of Bora phosphorylated by Cyclin B/Cdk1 (Tavernier et al., 2015) . Briefly, Bora is first phosphorylated by Cyclin B/Cdk1 (step 1) and then incubated with purified Plk1 and Aurora A in the presence of ATP (Figure 2A ). The first readout is the phosphorylation of Plk1 at residue T210, an indicator of Plk1 activity (Step 2). The second read-out is the hyperphosphorylation of Bora resulting from Plk1 activation, which leads to a higher mobility shift on SDS-PAGE (step 2) than the one due to Cdk1-dependent phosphorylation alone (step 1; Figure 2A ).
We tested Bora fragments lacking the C-terminal part, which is the less conserved part of the protein. We produced these fragments in bacteria fused to MBP (maltose-binding protein) or to the 6x(His) tag and obtained identical results (Figures 2A and  S2 ). Using this assay, we found that a Bora fragment containing the first 225 amino acids can promote Plk1 activation in vitro, as revealed by the appearance of Plk1 T210 phosphorylation and the mobility shift of Bora 1-225 (Figures 2A and S2) . Therefore, the N-terminal conserved fragment of Bora is sufficient to support Plk1 activation by Aurora A in vitro, and this depends on previous phosphorylation by Cdk1.
Three Conserved Phosphorylation Sites in Bora Are Critical for Plk1 Activation In Vitro Phosphorylation of SPAT-1, the C. elegans ortholog of Bora, promotes PLK-1 activation and mitotic entry in early embryos (Tavernier et al., 2015) . The critical Ser and Thr residues are located in the N-terminal half of SPAT-1, suggesting that, in both human cells and worms, the N-terminal part of the protein plays a crucial role in Plk1 activation. We therefore performed multiple protein sequence alignments of Bora and SPAT-1 from different species and found two interesting features ( Figure 2B ).
First, we identified two Cyclin-binding sites (Cy or RXL; Adams et al., 1996; Chen et al., 1996) in the N-terminal part of both SPAT-1 and Bora. One of these sites, S-L/T-R-R-K/R-L-F, is well conserved between Bora and SPAT-1 ( Figure 2B ), whereas the second motif is less conserved (PVGKKLTI for Bora and LDLKKLG for SPAT-1; data not shown). The presence of Cy motifs in the N-terminal part of Bora is consistent with our findings that Cyclin B/Cdk1 efficiently phosphorylates these proteins and that Cyclin B specifically co-immunoprecipitated with FLAG-Bora ( Figure 1C ). Second, we found that three phosphorylated residues are well conserved among species ( Figure 2B ), suggesting that these residues may play a critical role for the function of Bora and SPAT-1.
We therefore asked whether the Cy motifs and these three conserved phosphorylation sites are important, in vitro, for the ability of Bora to promote activation of Plk1. Mutating the Cy motifs drastically reduced Bora phosphorylation by Cyclin B/Cdk1 in vitro ( Figure S3A ) and abrogated Bora binding to Cyclin B in vivo, as revealed by co-immunoprecipitation experiments (Figure S3B) , indicating that these Cy motifs are functional. Bora 1-225 mutated on the Cy motifs failed to support Cdk1-dependent Plk1 activation in vitro ( Figures 2C and S2 ). Likewise, Bora 1-225 mutated on the three conserved phosphorylation sites (S41A, S112A, and S137A) was inactive in vitro ( Figure 2C ).
Therefore, phosphorylation of Bora by Cyclin B/Cdk1 on three conserved sites is critical for Plk1 activation in vitro.
Phosphorylation of Three Conserved Residues Is Important for Bora Function in Human Cells
We next asked whether phosphorylation of the three conserved residues is important for the function of Bora in human cells.
Although Plk1 is not strictly required for G2-M transition, Plk1 and Bora are crucial for G2-checkpoint recovery from DNA damage (van Vugt et al., 2004; Mac urek et al., 2008; Figures 3A and 3B) .
We thus investigated the role of Bora phosphorylation during this transition using an assay described in Figure 3A . We induced DNA damage using Doxorubicin, triggering G2 arrest.
We then forced G2-arrested cells to enter mitosis with caffeine and arrested them again in prometaphase using nocodazole. We then measured the mitotic index using an antibody against pS10-histone H3. Consistent with previous findings (Mac urek et al., 2008) , depletion of Bora, or chemical inhibition of Plk1, abrogated recovery from the arrest ( Figures 3B, 3C , and 3E). (E) Western blot analyses of control or FLAG immunoprecipitates (IP) of FLAG-Bora-expressing HEK293 cells 4 hr after release from the thymidine block using FLAG (top) and Cyclin B1 (bottom) antibodies. 30 mg of the total extracts (input) was loaded for comparison. (F) Schematic sequence of Bora with the positions of each phospho-residues identified in the different experimental settings. See also Figure S1 and Table S1 . 
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Step 1 Aurora A Plk1 T210
Step 2 
Cy motif S41/ S119 S112/ S190 S137/ T229 Next, we depleted Bora in HeLa cells previously transfected with small interfering RNA (siRNA)-resistant versions of Bora wild-type (GFP-Bora R ) or mutated on the three conserved phosphorylation sites (GFP-Bora RS41A,S112A,S137A , hereafter GFP-Bora R3A ) ( Figures 3D, 3F , and S4). GFP-Bora R rescued the checkpoint recovery defect caused by Bora depletion, whereas GFP-Bora R3A showed a mitotic index similar to the one caused by Bora depletion alone, indicating that Bora
R3A
is not functional in promoting checkpoint recovery ( Figure 3D ). These results are consistent with our observation that the Bora fragment mutated on the three conserved sites is unable to support Cdk1-dependent Plk1 activation in vitro ( Figure 2C ). We then monitored Plk1 T210 phosphorylation upon expression of Bora R or Bora R3A in human cells. Plk1 T210 phosphorylation was decreased in cells expressing the Bora R3A transgene when compared to Bora R ( Figure 3F, left) . Furthermore, the amount of total and active Plk1 co-immunoprecipitating with Bora R3A was reduced as compared to Bora R , suggesting that Bora phosphorylation on these three sites promotes Bora binding to Plk1 and activation ( Figure 3F , right). This observation is consistent with our previous findings in C. elegans that For the histograms, mean ± SD is shown. Statistical significance was determined using Student's t test: ns, p > 0.05, *p < 0.05, **p < 0.01, and ***p < 0.001. (E) Western blot of HeLa K cells lysates after G2-checkpoint recovery. The membrane was blotted using an anti-pSerine10 Histone3 antibody (bottom) and an anti-PCNA antibody (top).
(F) Western blot of HeLa K cell lysates (20 mg, left) and GFP-Bora immunoprecipitates from HeLa K cell lysates (right). The membrane was blotted using an anti-Bora antibody (top) an anti-pT210-Plk1 antibody (middle). The middle panel was stripped and blotted with anti-Plk1 antibody (bottom). See also Figure S4 .
phosphorylation of SPAT-1 is important for the interaction with PLK-1 (Tavernier et al., 2015) . We conclude that the three conserved phosphorylation sites are important for the function of Bora in promoting Plk1 activation and recovery from the DNA damage checkpoint in human cells.
SPAT-1 Phosphorylation on Three Conserved Sites Is Essential to Promote Timely Mitotic Entry in the Embryo
We next asked whether these three sites are crucial for the C. elegans ortholog SPAT-1 to regulate mitotic entry timing in the embryo. The first division of the embryo generates two blastomeres, AB and P1, different in size, fate, and cell-cycle timing. The cell-cycle length of AB and P1 is highly reproducible and can be monitored using differential interference contrast (DIC) microscopy by measuring the elapsed time between the first and the second division. Inactivation of SPAT-1 or PLK-1 delays mitotic entry in both AB and P1 (Budirahardja and Gö nczy, 2008; Rivers et al., 2008; Noatynska et al., 2010) . Cdk1 phosphorylates 13 sites on SPAT-1 in vitro, and a transgene with these sites mutated to alanine is not able to rescue the cell division delay caused by depletion of endogenous SPAT-1 (Tavernier et al., 2015) . We previously found that SPAT-1-depleted C. elegans embryos expressing an S119A or S190A SPAT-1 transgene are delayed in mitotic entry, both in AB and P1. We were however unable to test the contribution of the third, conserved phosphorylation site (T229) (Tavernier et al., 2015) . Here, we found that embryos expressing a SPAT-1 transgene mutated at T229 (corresponding to S137 in Bora) were also delayed in mitotic entry ( Figures 4A and 4B) . Embryos expressing SPAT-1 mutated simultaneously on all three residues (S119A, S190A, and T229A) were severely delayed in mitotic entry and displayed a cell-cycle length similar to embryos expressing SPAT-1 mutated on the 13 phosphorylation sites or on the Cy motifs (Figures 4A and 4B ; Table S2; Tavernier et al., 2015) , suggesting that these SPAT-1 mutants are defective in PLK-1 activation. Table S2 .
Accordingly, a SPAT-1 version mutated on the three conserved sites failed to promote PLK-1 phosphorylation by AIR-1 (C. elegans ortholog of Aurora A) when the three proteins were co-expressed in insect Sf9 cells ( Figure 4C ).
These data show that the three conserved Cdk1-dependent sites in SPAT-1 are required for PLK-1 activation and regulation of cell division timing in C. elegans embryos.
DISCUSSION
Plk1 plays a pivotal role in multiple cell division processes. Plk1 is activated by the conserved protein Bora, which facilitates Plk1 phosphorylation by the Aurora A kinase on its activation loop (Mac urek et al., 2008; Seki et al., 2008b ). The exact mechanism by which Bora activates Plk1 is incompletely understood, but it is possible that Bora promotes structural rearrangement of Plk1, exposing its activation loop to Aurora A (Xu et al., 2013) . Alternatively, Bora may activate Aurora A to specifically phosphorylate Plk1 at T210. Here, we reveal that the N-terminal 225 amino acids of Bora (Bora-NT) are sufficient for Plk1 activation in vitro and that phosphorylation on three conserved residues of this fragment by Cyclin B/Cdk1 is essential for its function as Plk1 activator. Interestingly, this fragment of Bora does not contain the Polo docking site (S252) (Chan et al., 2008) , which is consistent with the data in C. elegans where mutations of the Polo docking site did not impair SPAT-1 function (Tavernier et al., 2015) . Phosphorylation of the three conserved residues in SPAT-1 is also required for C. elegans PLK-1 activation in vitro. These sites are crucial for Bora and SPAT-1 function in vivo, in human cells to promote mitotic entry after DNA damage, and in C. elegans to regulate the timing of embryonic divisions.
What is the role of these three conserved phosphorylation sites? SPAT-1 and Bora appear to lack a well-structured threedimensional fold. Intrinsically disordered regions or proteins fold upon binding to their target in a process known as ''coupled folding and binding'' (Wright and Dyson, 2015) . The three phosphorylation sites are located in close proximity to each other, within less than 100 amino acids. Phosphorylation of them may promote folding and binding of Bora to Plk1, consistent with our finding that GFP-Bora R3A co-immunoprecipitates less total Plk1.
Further structural analysis of the minimal Bora fragment, phosphorylated by Cyclin B/Cdk1 and in complex with Plk1 and Aurora A, will be required to elucidate the real function of Bora and its phosphorylation in the binding to Plk1 and its activation.
Besides the three conserved sites, Cyclin B/Cdk1 phosphorylates Bora and SPAT-1 at many other sites. Whereas phosphorylation on T52 is known to block Bora degradation (Feine et al., 2014) , the contribution of the other sites to Bora function is yet unknown. As we discussed previously (Tavernier et al., 2015) , these sites could buffer the activity of the Cyclin B/Cdk1 kinase, making Plk1 activation by Cdk1 ultrasensitive similar to what has been shown for Wee1 (Kim and Ferrell, 2007) .
Our data indicate that Cdk1 is an activator of Plk1 during checkpoint recovery, suggesting the existence of a feedback loop involving Bora phosphorylation. What can be the trigger of this putative feedback loop? Activation of the DNA damage checkpoint must result in inhibition of Cdk1 to prevent cellcycle progression. However, low levels of active Cdk1 are kept during DNA damage arrest and are required for the activity of the Forkhead transcription factor FoxM1 (Alvarez-Ferná ndez et al., 2010) , which is essential for the expression of G2-specific genes including plk1, cyclin b, and bora (Wang et al., 2005) . Cdk1 activity is thus required to maintain expression of mitotic inducers during DNA damage, which then engage in positive feedback loop during recovery, with Cdk1 activating Plk1 via Bora phosphorylation and, conversely, Plk1 reinforcing Cdk1 activation via Cdc25 activation and Wee1 inhibition.
Given the central role of Plk1 in G2-checkpoint recovery after DNA damage, it is not surprising to observe Plk1 overexpression in many cancers in correlation with more aggressiveness and poor prognosis (Eckerdt et al., 2005) . Elucidating the mechanisms underlying Plk1 activation is of critical importance for the understanding of cancer progression and for the development of new therapeutic approaches.
EXPERIMENTAL PROCEDURES Plasmid Construction and Antibodies
All plasmids used in this study and their construction is described in Supplemental Information and in Table S3 . Antibodies used in this study are described Supplemental Experimental Procedures.
Cell Culture Methods and G2 DNA Damage Checkpoint Assay HEK293 and HeLa Kyoto (HeLa K) cells were grown in DMEM (Gibco) supplemented with 10% fetal bovine serum (FBS; Gibco), 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (Invitrogen).
Transient DNA expression in HeLa K was performed using X-tremeGene 9 according to the manufacturer's instructions (Roche). Stably transfected HEK293 cells expressing FLAG-tagged Bora were generated using the pMX-pie-pDest vector as described previously (Olma et al., 2009 ). The cells were selected in complete DMEM supplemented with 1 mg/ml puromycin.
HeLa K cells were transfected with a previously validated siRNA targeting endogenous Bora with the following sequence: 5 0 -UAACUAGUCCUUCGC CUAUUUdTdT-3 0 (Dharmacon, (Chan et al., 2008) ). A scramble siRNA with the sequence 5 0 -GGACCUGGAGGUCUGCUGUdTdT-3 0 (QIAGEN) was used as control. siRNA transfection of HeLa K was carried out using Lipofectamine RNAiMAX transfection reagent according to the manufacturer's instructions (Invitrogen). HEK293 cells were synchronized at the G1/S boundary by a double thymidine block. Briefly, after treatment for 24 hr with 2.5 mM thymidine, the cells were washed three times with serum-free DMEM and released into fresh complete DMEM for 12 hr. Then the cells were treated again with 2.5 mM thymidine for 24 hr. After three washes, the cells were released into fresh medium, after which samples were taken at regular intervals for subsequent analysis.
Spodoptera frugiperda (Sf9) cells were grown a 27 C in Insect-X press (Lonza) supplemented with 2 mM L-glutamine. For the G2-checkpoint recovery assay, HeLa K cells were transfected with the different Bora constructs. The cells were then transfected with the siRNA targeting endogenous Bora. DNA damage was induced by treating the cells with 100 nM doxorubicin (Sigma) for 1 hr; the culture medium was then replaced with fresh DMEM containing 5 mM caffeine and 100 ng/ml nocodazole (both from Sigma). The latter medium was supplemented with an additional 100 nM BI2536 (Selleckchem) when indicated. After 9-hr incubation, cells were fixed with cold 100% methanol, stained with pS10-H3 antibody (Abcam), counterstained with DAPI, and counted under the microscope. For Aurora A-dependent kinase assays, 200-300 ng 6x(His)-Bora previously phosphorylated or not by Cyclin B/Cdk1 was incubated in 50 mM Tris (pH 7.5), 15 mM MgCl 2 , 2 mM EGTA, 1 mM DTT, and protease and phosphatase inhibitor cocktails in the presence of 120 ng 6x(His)-Plk1 (Millipore) and 120 ng 6x(His)-Aurora A (Invitrogen). Reactions were initiated by adding a mix of 0.2 mM ATP for 30 min at 30 C.
Biochemical Assays

Immunoprecipitation and Western Blotting
Whole-cell extracts were prepared from mammalian cells by lysis in 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.27 M sucrose, 1% Triton X-100, complete protease inhibitor cocktails, and phosphatase inhibitor PhosSTOP (Roche) for 30 min on ice before clarification by centrifugation. FLAG-tagged proteins were isolated by immunoprecipitation from 1 to 2 mg cell lysate using 10 ml M2-FLAG beads (Sigma) for 2 hr at 4 C. All immunoprecipitations were washed in lysis buffer to remove nonspecific binding before elution by boiling in Laemmli sample buffer. To detect protein in cell lysates, protein samples were separated by SDS-PAGE and transferred onto nitrocellulose. Proteins were detected by immunoblotting and visualized by treating the blots with ECL (Millipore). For Figures 3E and S4 , HeLa K cells were lysed using the following protocol: Cells were washed with PBS and then lysed in a solution of 150 mM Tris-HCl (pH 7.5), 5% SDS, and 25% glycerol warmed to 95 C and scraped from the well. The samples were then boiled for 5 min, sonicated, and centrifuged. The supernatant was used to perform SDS-PAGE followed by western blot as described above. For Figure 3F , HeLa K cells were lysed in lysis buffer composed of 50 mM Tris-HCl (pH 7.5), 150 mM KCl, 5 mM MgCl 2 , 5% glycerol, 1% Triton X-100, 2 mM 2-mercaptoethanol, PhosSTOP phosphatase inhibitor (Roche), and complete protease inhibitor (Roche). GFP-tagged proteins were isolated by immunoprecipitation of 3 mg lysate using 15 ml GFP-Trap beads (Chromotek) for 2 hr at 4 C. After immunoprecipitation, beads were washed with lysis buffer and resuspended in Laemmli buffer. Proteins were then separated by SDS-PAGE and used for western blot.
Protein extracts of C. elegans embryos and western blot analysis were performed as described elsewhere (Tavernier et al., 2015) .
Nematode Experiments and Microscopy
Nematode strains, culture conditions, and RNAi are described in the Supplemental Experimental Procedures.
Cell-cycle length measurement in C. elegans early embryos was performed as described in Tavernier et al. (2015) . For time-lapse imaging, early embryos were extracted from gravid worms in egg buffer (118 mM NaCl, 48 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , and 25 mM HEPES [pH 7.3] ) and mounted on a 2% agarose pad. A Leica DM6000 microscope (Leica Microsystems) equipped with epifluorescence and DIC optics and a DFC 360 FX camera (Leica) was used to record divisions at room temperature (21 C). Images were collected every 10 s using a 633/1.4 numerical aperture (NA) objective and the LAS AF software (Leica Microsystems). Expression of the transgene was checked in each embryo recorded to ensure that the phenotype is not due to loss of expression. Images to quantify the cumulative mitotic index in the G2-checkpoint recovery assay were acquired with the same Leica microscope mentioned above. Images were collected using a 203/1.4 NA objective and the LAS AF software (Leica). Image processing and analysis were carried on using Fiji software.
Multiple Protein Alignments
The multiple protein alignments displayed were performed using sequences available on UniProt: Q6PGQ7 (human), Q8BS90 (mouse), Q5M864 (rat), Q6DJL7 (Xenopus), Q5U3U6 (fish), Q9VVR2 (Drosophila), G5ECT7 (C. elegans), and E3LRJ7 (C. vulgaris). The sequences were aligned using PRALINE software (http://www.ibi.vu.nl/programs/pralinewww/) with the default settings. The sequence surrounding S137/T229 (position 134-140 on human protein) was aligned manually using a BLOSUM62 matrix.
LC-MS/MS Analysis and Data Processing
Mass spectrometry analysis and data processing are described in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, four figures, and three tables and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2016.03.049.
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